These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 1812497
1. Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Herrmann WM, Schärer E, Wendt G, Delini-Stula A. Pharmacopsychiatry; 1991 Nov; 24(6):206-13. PubMed ID: 1812497 [Abstract] [Full Text] [Related]
2. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Herrmann WM, Schärer E, Wendt G, Delini-Stula A. Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498 [Abstract] [Full Text] [Related]
3. Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine. Herrmann WM, Schärer E, Delini-Stula A. Pharmacopsychiatry; 1991 Nov; 24(6):196-205. PubMed ID: 1687485 [Abstract] [Full Text] [Related]
4. Pharmacological profile of the new antidepressant levoprotiline. Noguchi S, Okada M, Inukai T. Arzneimittelforschung; 1992 Jun; 42(6):787-94. PubMed ID: 1418032 [Abstract] [Full Text] [Related]
5. [Dynamics of the effects of levoprotiline and maprotiline on EEG in patients with major depressive episodes (DSM-III-R)]. David I, Filip V, Höschl C, Albrecht V, Palus M, Seifertová D, Prasková H. Cesk Psychiatr; 1993 Jun; 89(3):123-9. PubMed ID: 8353827 [Abstract] [Full Text] [Related]
6. [Results of a clinical trial of levoprotiline]. Höschl C, Filip V, Bornová L, David I, Karen P, Seifertová D. Cesk Psychiatr; 1992 Jun; 88(2):97-105. PubMed ID: 1505054 [Abstract] [Full Text] [Related]
7. Pharmaco-EEG profiles of typical and atypical antidepressants. Saletu B. Adv Biochem Psychopharmacol; 1982 Jun; 32():257-68. PubMed ID: 7090895 [Abstract] [Full Text] [Related]
8. Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging). Saletu B, Anderer P, Kinsperger K, Grünberger J. Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):385-408. PubMed ID: 2888937 [Abstract] [Full Text] [Related]
9. [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry]. Saletu B, Grünberger L, Linzmayer L, Wittek R, Stöhr H. Wien Klin Wochenschr; 1983 Jul 08; 95(14):481-93. PubMed ID: 6356628 [Abstract] [Full Text] [Related]
10. Predicting therapeutic results with levoprotiline and maprotiline in major depression: the role of the outcome criteria. Filip V, Höschl C, Karen P, Seifertová D, Bornová L, Prasková H, Prasko J. Br J Psychiatry Suppl; 1993 Sep 08; (21):35-8. PubMed ID: 8217066 [Abstract] [Full Text] [Related]
11. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers]. Nobuhara K. Seishin Shinkeigaku Zasshi; 1993 Sep 08; 95(5):392-416. PubMed ID: 8356168 [Abstract] [Full Text] [Related]
12. A clinical test of noradrenergic involvement in the therapeutic mode of action of an experimental antidepressant. Katz RJ, Lott M, Landau P, Waldmeier P. Biol Psychiatry; 1993 Feb 15; 33(4):261-6. PubMed ID: 8471679 [Abstract] [Full Text] [Related]
13. CNS effects of citalopram, a new serotonin inhibitor antidepressant (a quantitative pharmaco-electroencephalography study). Itil TM, Menon GN, Bozak MM, Itil KZ. Prog Neuropsychopharmacol Biol Psychiatry; 1984 Feb 15; 8(3):397-409. PubMed ID: 6592676 [Abstract] [Full Text] [Related]
14. Changes in the rat brain 5-HT1A and 5-HT2 receptors after chronic administration of levoprotiline, (+)-oxaprotiline and other antidepressant drugs. Klimek V, Zak-Knapik J, Cannizzaro C. Pol J Pharmacol Pharm; 1992 Feb 15; 44(6):549-60. PubMed ID: 1305956 [Abstract] [Full Text] [Related]
15. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial. Schmauss M, Laakmann G, Dieterle D, Blaschke D. Pharmacopsychiatry; 1985 Jul 15; 18(4):282-5. PubMed ID: 3895255 [Abstract] [Full Text] [Related]
16. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation. Saletu B, Barbanoj MJ, Anderer P, Sieghart W, Grünberger J. Methods Find Exp Clin Pharmacol; 1993 Jun 15; 15(5):291-312. PubMed ID: 8412414 [Abstract] [Full Text] [Related]
17. Single treatments with the antidepressant oxaprotiline and its (+) and (-) enantiomers increase behavioural responses to dopaminergic stimulation in the rat. Delini-Stula A, Mogilnicka E. J Neural Transm; 1988 Jun 15; 71(2):91-8. PubMed ID: 3346651 [Abstract] [Full Text] [Related]
18. Oxaprotiline: enantioselective noradrenaline uptake inhibition indicated by intravenous amine pressor tests but not alpha 2-adrenoceptor binding to intact platelets in man. Reimann IW, Firkusny L, Antonin KH, Bieck PR. Eur J Clin Pharmacol; 1993 Jun 15; 44(1):93-5. PubMed ID: 8382162 [Abstract] [Full Text] [Related]
19. Comparison of effect of levoprotiline and dosulepine on cardial functions. Rysánek R, Mayer P, Náhunek K, Svestka J, Cesková E. Act Nerv Super (Praha); 1989 Dec 15; 31(4):283. PubMed ID: 2638112 [No Abstract] [Full Text] [Related]
20. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study. Wolfersdorf M, Wendt G, Binz U, Steiner B, Hole G. Pharmacopsychiatry; 1988 Jul 15; 21(4):203-7. PubMed ID: 3060885 [Abstract] [Full Text] [Related] Page: [Next] [New Search]